MedTrace Logo

RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence

NCT01409421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2015-10-01

No results posted yet for this study

Summary

The investigators are studying motivational interviewing (MI). MI is a counseling method to help people adopt healthy behaviors. The investigators will test whether MI improves patients' accurate use of glaucoma eye drops. The investigators will train eye clinic staff called glaucoma educators to use MI. Up to 250 patients at 3 clinics will be recruited. All patients will receive their usual eye care. Based on chance, some patients will also be supported by a glaucoma educator. The groups will be compared on medication adherence using micro-electro-mechanical system(MEMS). MEMS are electronic bottle caps that track when a medication bottle is opened. Patients will be aware that their medication use is tracked. The groups will also be compared on treatment value, outcomes, and cost. The investigators will also collect data on variables that may predict medication adherence.

Conditions

  • Primary Open Angle Glaucoma

Interventions

BEHAVIORAL

motivational interviewing

counseling intervention

BEHAVIORAL

three phone calls to remind patients to take their eye drops

reminder phone calls

Sponsors & Collaborators

Principal Investigators

  • Malik Kahook, MD · Lions Eye Inst. UC Denver

  • Paul F Cook, Ph.D · UC Denver, College of Nursing

  • Jeffery Kammer, MD · Vanderbilt University- Opthamology

  • Steve Mansberger, MD · Devers Eye Inst. Oregon

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01409421 on ClinicalTrials.gov